Could LLMs help design our next medicines and materials?
A new method lets users ask, in plain language, for a new molecule with certain properties, and receive a detailed description of how to synthesize it.
Study suggests new molecular strategy for treating fragile X syndrome
Enhancing activity of a specific component of neurons’ “NMDA” receptors normalized protein synthesis, neural activity, and seizure susceptibility in the hippocampus of fragile X lab mice.
Toward video generative models of the molecular world
Starting with a single frame in a simulation, a new system uses generative AI to emulate the dynamics of molecules, connecting static molecular structures and developing blurry pictures into videos.
A new computational model can predict antibody structures more accurately
Using this model, researchers may be able to identify antibody drugs that can target a variety of infectious diseases.
When MIT’s interdisciplinary NEET program is a perfect fit
Junior Katie Spivakovsky describes her path through New Engineering Education Transformation to biomedical research and beyond.
MIT chemists synthesize plant-derived molecules that hold potential as pharmaceuticals
Large multi-ring-containing molecules known as oligocyclotryptamines have never been produced in the lab until now.
When an antibiotic fails: MIT scientists are using AI to target “sleeper” bacteria
Most antibiotics target metabolically active bacteria, but with artificial intelligence, researchers can efficiently screen compounds that are lethal to dormant microbes.
Using AI, MIT researchers identify a new class of antibiotic candidates
These compounds can kill methicillin-resistant Staphylococcus aureus (MRSA), a bacterium that causes deadly infections.
Nanoparticle-delivered RNA reduces neuroinflammation in lab tests
MIT researchers find that in mice and human cell cultures, lipid nanoparticles can deliver a potential therapy for inflammation in the brain, a prominent symptom in Alzheimer’s.
Future science at the molecular level
Brad Pentelute and his lab compel the anthrax delivery system to deliver antibody and peptide variants into cells to treat cancer.
Molecule reduces inflammation in Alzheimer’s models
A potential new Alzheimer’s drug represses the harmful inflammatory response of the brain’s immune cells, reducing disease pathology, preserving neurons, and improving cognition in preclinical tests.
How to help high schoolers prepare for the rise of artificial intelligence
A one-week summer program aims to foster a deeper understanding of machine-learning approaches in health among curious young minds.
Learning the language of molecules to predict their properties
This AI system only needs a small amount of data to predict molecular properties, which could speed up drug discovery and material development.
New model offers a way to speed up drug discovery
By applying a language model to protein-drug interactions, researchers can quickly screen large libraries of potential drug compounds.
Using AI, scientists find a drug that could combat drug-resistant infections
The machine-learning algorithm identified a compound that kills Acinetobacter baumannii, a bacterium that lurks in many hospital settings.